Your browser doesn't support javascript.
loading
CDCA4 as a novel molecular biomarker of poor prognosis in patients with lung adenocarcinoma.
Tan, Jianlong; Chen, Fengyu; Ouyang, Bin; Li, Xiuying; Zhang, Weidong; Gao, Xinglin.
Afiliação
  • Tan J; The Second School of Clinical Medicine, Southern Medical University, Guangzhou, China.
  • Chen F; Department of Geriatric Respiratory Medicine, Guangdong Provincial People's Hospital, Guangdong Academy of Medical Sciences, Guangdong Provincial Geriatrics Institute, Guangzhou, China.
  • Ouyang B; Department of Pulmonary and Critical Care Medicine, Hunan Provincial People's Hospital, The First Affiliated Hospital of Hunan Normal University, Changsha, China.
  • Li X; Department of Pulmonary and Critical Care Medicine, Hunan Provincial People's Hospital, The First Affiliated Hospital of Hunan Normal University, Changsha, China.
  • Zhang W; Department of Pulmonary and Critical Care Medicine, Hunan Provincial People's Hospital, The First Affiliated Hospital of Hunan Normal University, Changsha, China.
  • Gao X; Department of Pulmonary and Critical Care Medicine, Hunan Provincial People's Hospital, The First Affiliated Hospital of Hunan Normal University, Changsha, China.
Front Oncol ; 12: 865756, 2022.
Article em En | MEDLINE | ID: mdl-36185189
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Tipo de estudo: Prognostic_studies Idioma: En Ano de publicação: 2022 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Tipo de estudo: Prognostic_studies Idioma: En Ano de publicação: 2022 Tipo de documento: Article